Trending - Altmetric
- ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor ImmunityLast mentioned on Wed Jan 20 2021
- IL1β promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin DLast mentioned on Thu Jan 21 2021
- At the Crossroads: COVID-19 and Immune Checkpoint Blockade for CancerLast mentioned on Wed Jan 20 2021
- The tumor microenvironment impairs Th1 IFNγ secretion through alternative splicing modifications of Irf1 pre-mRNALast mentioned on Tue Jan 19 2021
- Microsatellite-Stable Tumors with High Mutational Burden Benefit from ImmunotherapyLast mentioned on Tue Jan 19 2021
- Pathogen-Boosted Adoptive Cell Transfer Therapy Induces Endogenous Antitumor Immunity through Antigen SpreadingLast mentioned on Mon Jan 18 2021
- Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in MelanomaLast mentioned on Wed Jan 13 2021
- Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLCLast mentioned on Wed Jan 13 2021
- Activin A Promotes Regulatory T-cell–Mediated Immunosuppression in Irradiated Breast CancerLast mentioned on Thu Jan 07 2021
- Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient ObesityLast mentioned on Tue Jan 05 2021
- Radiotherapy Cooperates with IL15 to Induce Antitumor Immune ResponsesLast mentioned on Wed Jan 20 2021
- Antitumor effects of CAR T cells redirected to the EDB splice variant of fibronectinLast mentioned on Thu Dec 24 2020
- Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti–PD-1 TherapyLast mentioned on Wed Jan 20 2021
- An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor RegressionLast mentioned on Mon Jan 18 2021
- CD28 Costimulatory Domain–Targeted Mutations Enhance Chimeric Antigen Receptor T-cell FunctionLast mentioned on Wed Jan 20 2021
- Lighting a Fire: Can We Harness Pyroptosis to Ignite Antitumor Immunity?Last mentioned on Sat Jan 16 2021
- Personal Neoantigen Cancer Vaccines: A Road Not Fully PavedLast mentioned on Tue Dec 29 2020
- Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial CancerLast mentioned on Wed Jan 13 2021
- Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGFLast mentioned on Mon Jan 11 2021
- Immune Escape during Breast Tumor ProgressionLast mentioned on Mon Jan 11 2021
Pages